 The results of the study suggest that PLM is safe and effective for treating COVID-19 patients. It was found to reduce viral load and promote rapid viral clearance by inhibiting SARS-CoV-2 entry into cells through the inhibition of Galactin-3. This suggests that PLM may be a potential therapeutic option for treating COVID-19. This article was authored by Albin Sigomani, Kevin H. Mayo, Michelle C. Miller and others.